Detection of stable reference genes for real-time PCR analysis in schizophrenia and bipolar disorder

Analytical Biochemistry

Volumn 391, Issue 2, 2009, Pages 91-97

  Silberberg, Gilad ^a   Baruch, Kuti ^a   Navon, Ruth ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Bipolar disorder (BPD); Dorsolateral prefrontal cortex (DLPFC); GeNorm; NormFinder; Quantitative real time PCR (qPCR); Reference gene; Schizophrenia

Indexed keywords

BRAIN; DISEASES; GENE EXPRESSION;

BIPOLAR DISORDER; DORSOLATERAL PREFRONTAL CORTEX; GENORM; NORMFINDER; QUANTITATIVE REAL TIME PCR; REFERENCE GENES; SCHIZOPHRENIA;

POLYMERASE CHAIN REACTION;

ACIDIC RIBOSOMAL PHOSPHOPROTEIN P0; BETA 2 MICROGLOBULIN; BETA ACTIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; PHOSPHOPROTEIN; RNA 18S; RNA POLYMERASE; RNA POLYMERASE II POLYPEPTIDE A; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; HUMAN; HUMAN TISSUE; PREFRONTAL CORTEX; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SCHIZOPHRENIA;

EID: 67449149671     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2009.05.026     Document Type: Article

References (26)

1. Cardno A.G., Marshall E.J., Coid B., Macdonald A.M., Ribchester T.R., Davies N.J., et al. Heritability estimates for psychotic disorders: the Maudsley twin psychosis series. Arch. Gen. Psychiatry 56 (1999) 162-168
2. Kendler K.S. Genetic epidemiology in psychiatry: taking both genes and environment seriously. Arch. Gen. Psychiatry 52 (1995) 895-899
3. Tanney B. Psychiatric diagnoses and suicidal acts. In: Maris R.W., Berman A.L., and Silverman M.M. (Eds). Comprehensive Textbook of Suicidology (2000), Guilford, New York 311-341
4. Ginzinger D.G. Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream. Exp. Hematol. 30 (2002) 503-512
5. Heid C.A., Stevens J., Livak K.J., and Williams P.M. Real time quantitative PCR. Genome Res. 6 (1996) 986-994
6. Bustin S.A. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J. Mol. Endocrinol. 25 (2000) 169-193
7. Suzuki T., Higgins P.J., and Crawford D.R. Control selection for RNA quantitation. BioTechniques 29 (2000) 332-337
8. Thellin O., Zorzi W., Lakaye B., De Borman B., Coumans B., Hennen G., Grisar T., Igout A., and Heinen E. Housekeeping genes as internal standards: use and limits. J. Biotechnol. 75 (1999) 291-295
9. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., and Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3 (2002) RESEARCH0034
10. Warrington J.A., Nair A., Mahadevappa M., and Tsyganskaya M. Comparison of human adult and fetal expression and identification of 535 housekeeping/maintenance genes. Physiol. Genomics 2 (2000) 143-147
11. Andersen C.L., Jensen J.L., and Orntoft T.F. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res. 64 (2004) 5245-5250
12. Torrey E.F., Webster M., Knable M.B., Johnston N., and Yolken R.H. The Stanley foundation brain collection and neuropathology consortium. Schizophr. Res. 44 (2000) 151-155
13. Johansson S., Fuchs A., Ökvist A., Karimi M., Harper C., Garrick T., et al. Validation of endogenous controls for quantitative gene expression analysis: application on brain cortices of human chronic alcoholics. Brain Res. 1132 (2007) 20-28
14. Bahn S., Augood S.J., Ryan M., Standaert D.G., Starkey M., and Emson P.C. Gene expression profiling in the post-mortem human brain: no cause for dismay. J. Chem. Neuroanat. 22 (2001) 79-94
15. Harrison P.J., Heath P.R., Eastwood S.L., Burnet P.W., McDonald B., and Pearson R.C. The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: selective mRNA vulnerability and comparison with their encoded proteins. Neurosci. Lett. 200 (1995) 151-154
16. Lipska B.K., Deep-Soboslay A., Weickert C.S., Hyde T.M., Martin C.E., Herman M.M., and Kleinman J.E. Critical factors in gene expression in postmortem human brain: focus on studies in schizophrenia. Biol. Psychiatry 60 (2006) 650-658
17. Barrachina M., Castano E., and Ferrer I. TaqMan PCR assay in the control of RNA normalization in human post-mortem brain tissue. Neurochem. Int. 49 (2006) 276-284
18. Fedchenko V., Globa A., Kaloshin A., Kapitsa I., Nerobkova L., Val'dman E., Buneeva O., Glover V., and Medvedev A. The effect of short-term administration of (-)-deprenyl and isatin on the expressions of some genes in the mouse brain cortex. Med. Sci. Monit. 14 (2008) BR269-BR273
19. Raje C.I., Kumar S., Harle A., Nanda J.S., and Raje M. The macrophage cell surface glyceraldehyde-3-phosphate dehydrogenase is a novel transferrin receptor. J. Biol. Chem. 282 (2007) 3252-3261
20. Li Y., Nowotny P., Holmans P., Smemo S., Kauwe J.S.K., Hinrichs A.L., et al. Association of late-onset Alzheimer's disease with genetic variation in multiple members of the GAPD gene family. Proc. Natl. Acad. Sci. USA 101 (2004) 15688-15693
21. Lin P.I., Martin E.R., Bronson P.G., Browning-Large C., Small G.W., and Schmechel D.E. Exploring the association of glyceraldehydes-3-phosphate dehydrogenase gene and Alzheimer disease. Neurology 67 (2006) 64-68
22. Shalova I.N., Cechalova K., Rehakova Z., Dimitrova P., Ognibene E., Caprioli A., et al. Decrease of dehydrogenase activity of cerebral glyceraldehydes-3-phosphate dehydrogenase in different animal models of Alzheimer's disease. Biochim. Biophys. Acta 1770 (2007) 826-832
23. Tsuchiya K., Tajima H., Yamada M., Takahashi H., Kuwae T., Sunaga K., Katsube N., and Ishitani R. Disclosure of a pro-apoptotic glyceraldehydes-3-phosphate dehydrogenase promoter: anti-dementia drugs depress its activation in apoptosis. Life Sci. 74 (2004) 3245-3258
24. Kanai H., Sawa A., Chen R.W., Leeds P., and Chuang D.M. Valproic acid inhibits histone deacetylase activity and suppresses excitotoxicity-induced GAPDH nuclear accumulation and apoptotic death in neurons. Pharmacogenomics J. 4 (2004) 336-344
25. Dean B., Keriakous D., Scarr E., and Thomas E.A. Gene expression profiling in Brodmann's area 46 from subjects with schizophrenia. Aust. NZ J. Psychiatry 41 (2007) 308-320
26. O'Connor J.A., Muly E.C., Arnold S.E., and Hemby S.E. AMPA receptor subunit and splice variant expression in the DLPFC of schizophrenic subjects and rhesus monkeys chronically administered antipsychotic drugs. Schizophr. Res. 90 (2007) 28-40